본문 바로가기
KERD
논문KCI 등재

‘항암화학요법을 받은 폐암 환자의 예비 통합의학 임상경로’ 개발 및 타당도 평가

Development and Validity Test on Preliminary Critical Pathway of Integrative Medicine for Lung Cancer Patients Treated with Chemotherapy

1

조회

0

다운로드

7

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: The objective of this study was to investigate the validity of the preliminary critical pathway of integrative medicine to improve the quality of life of lung cancer patients who received chemotherapy. Methods: The vertical axis of the preliminary critical pathway of integrated medicine consisted of nine domains: assessment, treatment, activity, consult, diet, medication, Korean medical examination, education, and others. The frame of the horizontal axis was the date from hospitalization to discharge. A total of 105 items in this preliminary critical pathway were validated by an expert group from October 28, 2016 to November 4, 2016. A total of ten experts from two different medical institutions participated in the validity test, using the four-point Content Validity Index (CVI) scale. The items with validity of greater than 80% were considered as significant. Results: The analysis of the content validity of 105 items showed 102 items with greater than 80% agreement. Assessment, treatment, consult, diet, medication, and education showed 100% agreement. Only three items showed a low validity (62.5%). Based on additional comments, the preliminary critical pathway of integrative medicine has been supplemented. Conclusions: This study suggests the possibility of using the integrated medical critical pathway for patients with lung cancer who received chemotherapy.

Abstract

Objectives: The objective of this study was to investigate the validity of the preliminary critical pathway of integrative medicine to improve the quality of life of lung cancer patients who received chemotherapy. Methods: The vertical axis of the preliminary critical pathway of integrated medicine consisted of nine domains: assessment, treatment, activity, consult, diet, medication, Korean medical examination, education, and others. The frame of the horizontal axis was the date from hospitalization to discharge. A total of 105 items in this preliminary critical pathway were validated by an expert group from October 28, 2016 to November 4, 2016. A total of ten experts from two different medical institutions participated in the validity test, using the four-point Content Validity Index (CVI) scale. The items with validity of greater than 80% were considered as significant. Results: The analysis of the content validity of 105 items showed 102 items with greater than 80% agreement. Assessment, treatment, consult, diet, medication, and education showed 100% agreement. Only three items showed a low validity (62.5%). Based on additional comments, the preliminary critical pathway of integrative medicine has been supplemented. Conclusions: This study suggests the possibility of using the integrated medical critical pathway for patients with lung cancer who received chemotherapy.

참고문헌 (31)

  1. Jemal A, "Global cancer statistics", CA Cancer J Clin, 61(2), pp.69~90 (2011)
  2. Kim YH, "Lung cancer guideline" (2010), Korean Association for Lung Cancer
  3. Park KC, "Chemotherapy in Lung Cancer", pp.38~45 (2003), The Korean Medical Association
  4. Pisters KM, "Adjuvant chemotherapy in completely resected non-small-cell lung cancer", J Clin Oncol, 23(14), pp.3270~3278 (2005)
  5. Hong MN, "Change of the Quality of Life among Lung Cancer Patients Treated with Chemotherapy and Development of Critical Pathway of Integrative Medicine", pp.2017
  6. Shim JK, "Fatigue and its Related Factors in Lung Cancer Patients on Chemotherapy", The chung-Ang Journal of Nursing, 7(1), pp.9~15 (2003)
  7. 임경태, "‘요추 수술 후 급성기 통증 환자의 예비 표준임상경로지 내용타당도 설문’ 조사 보고", 한방재활의학과학회지, 26(4), pp.77~83 (2016), 한방재활의학과학회
  8. Kim SA, "Development of CP (Critical Pathway)System for women's cancer patients Receiving Chemotherapy", pp.2006
  9. Kim MJ, "The Development of the Critical Pathway and Nursing Record for Patients received FP Chemotherapy", Korean J Adult Nurs, 11(4), pp.845~857 (1999)
  10. Choi JY, "Development of a Critical Pathway for the Chemotherapy of Non-small Cell Lung Cancer Patients and Its Effects", J Korean Acad Nurs Adm, 8(1), pp.85~95 (2002)
  11. Kwon SM, "development of critical pathway for patirnt with meningioma resection", pp.2004
  12. Kim SY, "Development of Critical Pathway for Gamma Knife Surgery Patients", pp.2005
  13. 김정아, "비중격 만곡증 수술환자의 표준임상경로지(Critical pathway)개발", 석사, 보건교육전공, pp.2013
  14. Yang SY, "Development of Clinical Application Program and Construction of Critical Pathways for Surgical Preventive Antibiotics Use", pp.2016
  15. Yong MS, "Development of critical pathway for the patient with microdiscecto", pp.2008
  16. Jang YS, "Development of a critical pathway for patients with malignant lymphoma", pp.2004
  17. Choe MJ, "Development of Critical Pathway toward ketogenic diet cure for children epilepsy cases", pp.2011
  18. Han SY, "Development and effects of critical pathway for Coronary Artery Bypass Grafting (CABG).", pp.2005
  19. Hong SH, "Development of a critical pathway for the patients undergoing anterior cervical discectomy and fusion", pp.2010
  20. Pignon JP, "Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group", J Clin Oncol, 26(21), pp.3552~3559 (2008)
  21. 이남수, "현재 사용되는 경구용 항암제", 대한의사협회지, 54(11), pp.1191~1198 (2011), 대한의사협회
  22. Kwon HK, "Review for the Status of Cancer Complementary and Alternative Medicine in the World", J Korean Tradit Oncol, 14(1), pp.1~11 (2009)
  23. 이은옥․이명선, "항암화학요법 주기에 따른 폐암환자의 피로 양상과 관련요인", Asian Oncology Nursing, 1(1), pp.54~64 (2001), 대한종양간호학회
  24. 김명화, "암환자의 보완대체요법 이용 양상", 농촌의학.지역보건, 32(3), pp.155~167 (2007), 한국농촌의학.지역보건학회
  25. 장순복, "우리나라 암환자가 이용하는 보완대체요법에 관한 연구", 성인간호학회지, 18(1), pp.92~101 (2006), 한국성인간호학회
  26. Jeong GS, "Experiences and attitudes of lung cancer patients receiving complementary and alternative therapies", pp.2006
  27. 최유진, "암 환자의 한의학 치료 이용 현황", 대한한의학회지, 33(3), pp.46~53 (2012), 대한한의학회
  28. 김도형, "폐암 환자에 대한 부가적인 침치료 효과 - 단일군, 전후, 예비임상 연구 -", 동의생리병리학회지, 28(1), pp.82~88 (2014), 한의병리학회
  29. 성연실, "내관(P6) 지압이 항암화학요법을 받는 폐암 환자의 오심과 구토,식욕부진에 미치는 영향", 동서간호학연구지, 16(1), pp.1~10 (2010), 동서간호학연구소
  30. Iwase S, "The clinical use of Kampo medicines (traditional Japanese herbal treatments)for controlling cancer patients' symptoms in Japan: a national cross-sectional survey", BMC Complement Altern Med, 12, pp.222~ (2012)
  31. Kasymjanova G, "The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study", Curr Oncol, 20(3), pp.152~157 (2013)

관련 논문AI추천

이 간행물의 다른 논문 (19건)